| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/25/1989 | US4824785 Canine corona virus vaccine |
| 04/25/1989 | US4824668 Attenuated infectious bursal disease virus strain and vaccine therefrom |
| 04/25/1989 | US4824667 Thymidine kinase deletion mutants of bovine herpesvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same |
| 04/25/1989 | US4824666 Method of large scale growth of toxoplasmic microorganisms |
| 04/25/1989 | US4824659 Antibody conjugates |
| 04/25/1989 | CA1253298A1 Synthetic picornavirus antigen |
| 04/25/1989 | CA1253093A1 Rabies vaccine and preparation process thereof |
| 04/25/1989 | CA1253090A1 Monoclonal anti-human breast cancer antibodies |
| 04/25/1989 | CA1253073A1 Antigenic preparations and isolation of such preparations |
| 04/25/1989 | CA1253069A1 Synthetic hepatitis b virus vaccine including both t cell and b cell determinants |
| 04/20/1989 | WO1989003429A1 Recombinant avipox virus |
| 04/20/1989 | WO1989003427A1 A method of maintaining a desired recombinant gene in a genetic population of cells |
| 04/20/1989 | WO1989003399A1 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 04/20/1989 | WO1989003398A1 Human monoclonal antibody against candida |
| 04/20/1989 | WO1989003397A1 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes |
| 04/20/1989 | WO1989003396A2 Antibodies to natural killer cell and non-specific cytotoxic cell receptor |
| 04/20/1989 | WO1989003391A1 Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc |
| 04/20/1989 | WO1989003207A1 A drug composition with microspheres and process for its preparation |
| 04/20/1989 | WO1989001783A3 Recombinant antibody and method |
| 04/19/1989 | EP0312222A1 Treatment of diseases caused by viruses |
| 04/19/1989 | EP0312173A2 Particle-stabilized epitopes for standardization and control of immunoassays |
| 04/19/1989 | EP0312164A1 Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells |
| 04/19/1989 | EP0312159A2 Method for producing hepatitis B virus proteins in yeast |
| 04/19/1989 | EP0311675A1 Immunotherapeutic methods and compositions |
| 04/18/1989 | US4822776 Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay) |
| 04/18/1989 | US4822734 Method for improving the elicitation of IgG class monoclonal antibodies to tumor-associated antigens and glycoproteins |
| 04/18/1989 | US4822732 Method of concentrating and detecting biomolecules and cells |
| 04/18/1989 | US4822611 Hexose monosaccharide and ethyl alcohol in water |
| 04/18/1989 | CA1252948A1 Process for purifying proteins |
| 04/18/1989 | CA1252744A1 Ultrapurification of factor ix and other vitamin k- dependent proteins |
| 04/18/1989 | CA1252722A1 Vaccines for the treatment of urinary tract infections |
| 04/18/1989 | CA1252721A1 Composition for prevention and treatment of mycoplasmal pneumonia |
| 04/18/1989 | CA1252720A1 Vaccine for cytomegalovirus |
| 04/18/1989 | CA1252714A1 Diagnostic agent for heart disease and use thereof |
| 04/13/1989 | DE3833319A1 Tumorantigene und adjuvantien enthaltende vakzine Tumor antigens and vaccines containing adjuvants |
| 04/12/1989 | EP0311228A2 Recombinant polypeptides and their uses, including assay for AIDS virus |
| 04/12/1989 | EP0311219A1 Oligopeptides and their use for diagnostic and vaccination purposes for AIDS and ARC |
| 04/12/1989 | EP0310719A1 Method for purification of antibodies |
| 04/12/1989 | EP0310716A1 A product, preparation and method for treating allergies |
| 04/12/1989 | CN1032346A Polymeric particules fixed amphoteric molecules with ionization or activation groups on surface, process of preparation and application in biology thereof |
| 04/11/1989 | US4820644 Process for the preparation of an immune-reactive porous carrier material |
| 04/11/1989 | US4820642 Over production of beta-lactamase by dna; vaccine against hepatitis b |
| 04/11/1989 | US4820641 Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells |
| 04/11/1989 | US4820629 Immunoassay for antibodies to pseudorabies virus using medium-elaborated viral antigenic factor |
| 04/11/1989 | US4820514 Low dosage of interferon to enhance vaccine efficiency |
| 04/11/1989 | CA1252388A1 Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay |
| 04/06/1989 | WO1989002935A1 Respiratory syncytial virus: vaccines and diagnostic assays |
| 04/06/1989 | WO1989002924A1 Vaccines for malaria |
| 04/06/1989 | WO1989002899A1 Monoclonal antibody that recognizes an epitope of the gamma chain of human t cell surface receptors |
| 04/06/1989 | WO1989002898A1 Reagents and probes for distinguishing and isolating different gtp-binding proteins |
| 04/06/1989 | WO1989002749A1 Process for the remission of symptoms associated with aids |
| 04/06/1989 | WO1989001490A3 Biologically active molecules |
| 04/05/1989 | EP0310413A2 Immobilized antibodies |
| 04/05/1989 | EP0310362A2 Vaccine for protection of cats against feline infectious peritonitis |
| 04/05/1989 | EP0310317A2 Inactivation of viruses and bacteria |
| 04/05/1989 | EP0310316A2 TGEV-virus of swine as a dog vaccine |
| 04/05/1989 | EP0310178A1 Recovery of pres2+S antigen |
| 04/05/1989 | EP0310136A2 Macrophage-derived inflammatory mediator (MIP-1alpha and MIP-1beta) |
| 04/05/1989 | EP0309898A2 Method for the induction of a cytotoxic T cell response |
| 04/05/1989 | EP0309863A2 Composition and method to release an immune reaction to GnRH and method for the immunosterilization of mammals |
| 04/05/1989 | EP0309746A1 Antimalaria vaccines |
| 04/05/1989 | EP0309555A1 Immunogenic polypeptide and method for purifying it |
| 04/05/1989 | EP0309548A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 04/04/1989 | US4818769 Method of controlling stress-related disease in livestock by administration of human IL-2 |
| 04/04/1989 | US4818763 Immunostimulants |
| 04/04/1989 | US4818694 Production of herpes simplex viral protein |
| 04/04/1989 | US4818688 Assays for antibody to hepatitis B core antigen |
| 04/04/1989 | US4818683 Radioactive material or enzyme tracer |
| 04/04/1989 | US4818682 In vitro detection of gastrointestinal cancer |
| 04/04/1989 | US4818528 Vaccine against infectious bovine keratoconjunctivitis |
| 04/04/1989 | US4818527 T cell epitopes of the hepatitis B virus nucleocapsid protein |
| 04/04/1989 | CA1252046A1 Methods for oncogenic detection |
| 04/04/1989 | CA1252043A1 Detection of cell membrane protein |
| 04/04/1989 | CA1252042A1 Infectious bursal disease virus vaccine |
| 03/29/1989 | EP0308936A2 Antibody heteroconjugates for the killing of HIV-infected cells |
| 03/29/1989 | EP0308724A2 Use of a immunistimulating biologic to manufacture a medicament to treat human immunodeficiency virus |
| 03/29/1989 | EP0308475A1 Adjuvant for certain antimitotic chemicals, obtained from vibrio cholerae |
| 03/29/1989 | EP0144367B1 Method and reagent for the direct detection of an analyte after the specific elimination of colloidal particles in aqueous solutions of biological origin |
| 03/28/1989 | US4816567 Immunology, vectors, dna |
| 03/28/1989 | US4816564 Method for producing hepatitis B virus proteins in yeast |
| 03/28/1989 | US4816561 Biologically active polypeptides |
| 03/28/1989 | US4816560 Storage stability |
| 03/28/1989 | US4816416 Microspheric bodies for use in screening therapies for Azheimer's disease and related conditions |
| 03/28/1989 | US4816409 Water insoluble antitumor monoclonal antibodies |
| 03/28/1989 | US4816397 Genetic engineering |
| 03/28/1989 | US4816253 Novel mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent |
| 03/28/1989 | US4816249 Monoclonal anti-idiotype antibodies |
| 03/28/1989 | CA1251747A1 Monoclonal antibody to candida albicans cytoplasmic antigens and methods of preparing same |
| 03/28/1989 | CA1251730A1 Method for exposing bacterial antigen and improved diagnostic assay using same |
| 03/23/1989 | WO1989002600A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 03/23/1989 | WO1989002443A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 03/23/1989 | WO1989002442A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 03/23/1989 | WO1989002278A1 Bivalent live vaccine for marek's disease and process for its preparation |
| 03/23/1989 | WO1989002277A2 Prophylaxis and therapy of acquired immunodeficiency syndrome |
| 03/23/1989 | WO1989002268A1 Pharmaceutical presentation potentializing the cytotrophic effect of animal and/or human sera and/or antitissue antibodies |
| 03/23/1989 | WO1989002220A1 Method and composition for enhancing animal fertility |
| 03/23/1989 | WO1989001973A3 Recombinant pox virus for immunization against tumor-associated antigens |
| 03/22/1989 | EP0308265A2 Methods and compositions relating to regression-associated antigens |
| 03/22/1989 | EP0308220A1 Recombinant avipoxvirus |
| 03/22/1989 | EP0308208A1 Modified antibody conjugates with enhanced clearance |